文献速递肝病

Stard1通过增敏胆汁酸肝毒性促进胆汁淤积性肝损伤与疾病进展

Stard1 promotes cholestatic liver injury and disease progression by sensitizing to bile acid hepatotoxicity.
PubMed 文献 · Hepatology · 2024-12-09

研究显示原发性胆汁性胆管炎患者STARD1表达升高;肝细胞特异性Stard1缺失小鼠对胆管结扎和化学性梗阻性胆汁淤积所致肝损伤、炎症和纤维化更具抵抗力,伴肝脏胆汁酸和线粒体胆固醇积累减少、线粒体谷胱甘肽升高;药理耗竭mGSH使原代小鼠肝细胞对胆汁酸混合物增敏。

要点

  • 原发性胆汁性胆管炎患者STARD1表达较对照升高。
  • 肝细胞Stard1缺失小鼠对梗阻性胆汁淤积损伤更具抵抗力。
  • Stard1缺失小鼠胆管结扎后肝脏胆汁酸和线粒体胆固醇积累减少、线粒体谷胱甘肽升高。

核心结论

  • STARD1在胆汁淤积性肝损伤中起作用,靶向其可能对胆汁淤积性肝病有意义。

研究设计与样本

  • 研究比较原发性胆汁性胆管炎患者与对照者的STARD1表达。
  • 使用肝细胞特异性Stard1缺失小鼠(Stard1Δhep)与Stard1f/f小鼠,在胆管结扎和化学性梗阻性胆汁淤积模型中比较肝损伤、炎症和纤维化。
  • 体外用药理耗竭mGSH处理原代小鼠肝细胞,并给予模拟Stard1f/f小鼠胆管结扎后谱的胆汁酸混合物。

主要发现

  • 原发性胆汁性胆管炎患者STARD1表达较对照者升高。
  • Stard1Δhep小鼠较Stard1f/f小鼠对完全(胆管结扎)和化学性梗阻性胆汁淤积所致肝损伤、炎症和纤维化更具抵抗力。
  • 胆管结扎后Stard1Δhep小鼠较Stard1f/f小鼠肝脏胆汁酸和线粒体胆固醇积累减少、线粒体谷胱甘肽水平升高。
  • 药理耗竭mGSH使原代小鼠肝细胞对模拟Stard1f/f小鼠胆管结扎后谱的胆汁酸混合物增敏,导致炎症反应和细胞毒性增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cholestatic liver diseases are often accompanied by hepatocellular injury, fibrosis, and cirrhosis due to the intracellular accumulation of solutes that cannot be excreted into bile, including bile acids (BAs). These are synthesized in hepatocytes from cholesterol mainly via the classic pathway and in a lower proportion through the mitochondrial acidic pathway. The latter requires STARD1-dependent cholesterol transport to the mitochondrial inner membrane for metabolism, whose contribution to BA-induced hepatotoxicity and cholestatic liver disease is unknown. APPROACH AND RESULTS: Here we show that patients with primary biliary cholangitis exhibit increased expression of STARD1 compared to control subjects. Mice with hepatocyte-specific Stard1 deletion ( Stard1Δhep ) were more resistant to experimental models of complete (bile duct ligation) and chemical obstructive cholestasis-induced liver injury, inflammation, and fibrosis than Stard1f/f mice. Stard1Δhep mice exhibited reduced hepatic BAs and mitochondrial cholesterol accumulation but increased mitochondrial glutathione levels following bile duct ligation compared to Stard1f/f mice. Pharmacological mGSH depletion sensitized primary mouse hepatocytes to a mix of BAs mimicking the profile seen in Stard1f/f mice after bile duct ligation leading to increased inflammatory response and cytotoxicity. CONCLUSIONS: These findings highlight a role for STARD1 in cholestatic liver injury and suggest that its targeting may be of relevance for cholestatic liver disease.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Conde de la Rosa L, Fàbrega L, Torres S, et al. Stard1 promotes cholestatic liver injury and disease progression by sensitizing to bile acid hepatotoxicity. Hepatology. 2024. PMID: 39652774. doi:10.1097/HEP.0000000000001184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。